

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | skeletal muscle adaptation (GO:0043501) | 9.93612448 |
| 2 | skeletal muscle fiber development (GO:0048741) | 8.61511071 |
| 3 | * actin filament-based movement (GO:0030048) | 8.00327040 |
| 4 | plasma membrane repair (GO:0001778) | 7.86252623 |
| 5 | myotube cell development (GO:0014904) | 7.35473694 |
| 6 | skeletal muscle tissue regeneration (GO:0043403) | 6.94794106 |
| 7 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 6.55602391 |
| 8 | sarcomere organization (GO:0045214) | 6.47202003 |
| 9 | * striated muscle contraction (GO:0006941) | 6.47020286 |
| 10 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 6.42222270 |
| 11 | creatine metabolic process (GO:0006600) | 6.30201478 |
| 12 | glycogen catabolic process (GO:0005980) | 6.24561098 |
| 13 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 6.14943371 |
| 14 | cytidine catabolic process (GO:0006216) | 6.03109697 |
| 15 | cytidine deamination (GO:0009972) | 6.03109697 |
| 16 | cytidine metabolic process (GO:0046087) | 6.03109697 |
| 17 | striated muscle atrophy (GO:0014891) | 5.95316872 |
| 18 | myofibril assembly (GO:0030239) | 5.84879281 |
| 19 | glucan catabolic process (GO:0009251) | 5.84442207 |
| 20 | * muscle contraction (GO:0006936) | 5.63818345 |
| 21 | purine nucleotide salvage (GO:0032261) | 5.60750117 |
| 22 | response to muscle activity (GO:0014850) | 5.54805383 |
| 23 | carnitine shuttle (GO:0006853) | 5.50012698 |
| 24 | response to inactivity (GO:0014854) | 5.49753709 |
| 25 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 5.49062939 |
| 26 | cellular polysaccharide catabolic process (GO:0044247) | 5.43329029 |
| 27 | regulation of cell communication by electrical coupling (GO:0010649) | 5.43015497 |
| 28 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 5.30028459 |
| 29 | polysaccharide catabolic process (GO:0000272) | 5.27060918 |
| 30 | striated muscle adaptation (GO:0014888) | 5.16726474 |
| 31 | muscle atrophy (GO:0014889) | 5.15244538 |
| 32 | muscle fiber development (GO:0048747) | 5.12067664 |
| 33 | * muscle system process (GO:0003012) | 5.00577683 |
| 34 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 4.97778825 |
| 35 | glucan biosynthetic process (GO:0009250) | 4.95488212 |
| 36 | glycogen biosynthetic process (GO:0005978) | 4.95488212 |
| 37 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 4.93112183 |
| 38 | NADH metabolic process (GO:0006734) | 4.70859852 |
| 39 | IMP metabolic process (GO:0046040) | 4.69785131 |
| 40 | fatty acid transmembrane transport (GO:1902001) | 4.67530316 |
| 41 | actomyosin structure organization (GO:0031032) | 4.62619326 |
| 42 | regulation of actin filament-based movement (GO:1903115) | 4.50530658 |
| 43 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 4.46130300 |
| 44 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 4.43919856 |
| 45 | cardiac muscle hypertrophy (GO:0003300) | 4.42941810 |
| 46 | regulation of skeletal muscle cell differentiation (GO:2001014) | 4.36254483 |
| 47 | glycogen metabolic process (GO:0005977) | 4.29459673 |
| 48 | negative regulation of muscle hypertrophy (GO:0014741) | 4.24574178 |
| 49 | striated muscle hypertrophy (GO:0014897) | 4.22499916 |
| 50 | fructose metabolic process (GO:0006000) | 4.20786458 |
| 51 | glucan metabolic process (GO:0044042) | 4.20764678 |
| 52 | cellular glucan metabolic process (GO:0006073) | 4.20764678 |
| 53 | muscle adaptation (GO:0043500) | 4.19930569 |
| 54 | regulation of relaxation of muscle (GO:1901077) | 4.15973912 |
| 55 | carnitine transmembrane transport (GO:1902603) | 4.07194255 |
| 56 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 4.04317500 |
| 57 | muscle organ development (GO:0007517) | 4.01608719 |
| 58 | muscle cell cellular homeostasis (GO:0046716) | 3.98031608 |
| 59 | muscle structure development (GO:0061061) | 3.95780768 |
| 60 | negative regulation of skeletal muscle tissue development (GO:0048642) | 3.93389324 |
| 61 | muscle organ morphogenesis (GO:0048644) | 3.90284119 |
| 62 | response to activity (GO:0014823) | 3.87732046 |
| 63 | 2-oxoglutarate metabolic process (GO:0006103) | 3.87391707 |
| 64 | cardiac muscle contraction (GO:0060048) | 3.85730857 |
| 65 | gluconeogenesis (GO:0006094) | 3.85044691 |
| 66 | skeletal muscle tissue development (GO:0007519) | 3.82859800 |
| 67 | muscle hypertrophy (GO:0014896) | 3.82750047 |
| 68 | myotube differentiation (GO:0014902) | 3.81584880 |
| 69 | striated muscle cell development (GO:0055002) | 3.79891458 |
| 70 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 3.78670220 |
| 71 | muscle tissue morphogenesis (GO:0060415) | 3.76227136 |
| 72 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 3.74161812 |
| 73 | carnitine transport (GO:0015879) | 3.70535863 |
| 74 | amino-acid betaine transport (GO:0015838) | 3.70535863 |
| 75 | positive regulation of myotube differentiation (GO:0010831) | 3.68030870 |
| 76 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 3.65850882 |
| 77 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.64913686 |
| 78 | regulation of coenzyme metabolic process (GO:0051196) | 3.63965418 |
| 79 | regulation of cofactor metabolic process (GO:0051193) | 3.63965418 |
| 80 | cellular response to dexamethasone stimulus (GO:0071549) | 3.63537386 |
| 81 | myoblast fusion (GO:0007520) | 3.59556163 |
| 82 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 3.55427705 |
| 83 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 3.55427705 |
| 84 | neuromuscular synaptic transmission (GO:0007274) | 3.54509187 |
| 85 | neuronal action potential propagation (GO:0019227) | 3.54336996 |
| 86 | IMP biosynthetic process (GO:0006188) | 3.54159174 |
| 87 | striated muscle tissue development (GO:0014706) | 3.51415778 |
| 88 | cardiac muscle tissue morphogenesis (GO:0055008) | 3.50424637 |
| 89 | negative regulation of muscle contraction (GO:0045932) | 3.46141693 |
| 90 | hexose biosynthetic process (GO:0019319) | 3.44475426 |
| 91 | adult heart development (GO:0007512) | 3.43548323 |
| 92 | cardiac muscle cell development (GO:0055013) | 3.42852779 |
| 93 | cellular carbohydrate catabolic process (GO:0044275) | 3.39789351 |
| 94 | response to dexamethasone (GO:0071548) | 3.37916068 |
| 95 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 3.35881686 |
| 96 | regulation of calcium ion transmembrane transport (GO:1903169) | 3.35881686 |
| 97 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 3.31652022 |
| 98 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 3.31410707 |
| 99 | tricarboxylic acid cycle (GO:0006099) | 3.30458552 |
| 100 | regulation of striated muscle contraction (GO:0006942) | 3.28097496 |
| 101 | syncytium formation (GO:0006949) | 3.27692823 |
| 102 | regulation of muscle system process (GO:0090257) | 3.26905852 |
| 103 | regulation of myotube differentiation (GO:0010830) | 3.26851768 |
| 104 | muscle cell fate commitment (GO:0042693) | 3.26361663 |
| 105 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 3.25676803 |
| 106 | syncytium formation by plasma membrane fusion (GO:0000768) | 3.24259017 |
| 107 | muscle cell development (GO:0055001) | 3.24038952 |
| 108 | cardiac muscle adaptation (GO:0014887) | 3.23968042 |
| 109 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 3.23968042 |
| 110 | muscle hypertrophy in response to stress (GO:0003299) | 3.23968042 |
| 111 | regulation of myoblast differentiation (GO:0045661) | 3.22108490 |
| 112 | negative regulation of protein localization to cell surface (GO:2000009) | 3.22077941 |
| 113 | regulation of sarcomere organization (GO:0060297) | 3.18655216 |
| 114 | positive regulation of myoblast differentiation (GO:0045663) | 3.17295621 |
| 115 | keratinization (GO:0031424) | 3.13524649 |
| 116 | cardiac myofibril assembly (GO:0055003) | 3.11035238 |
| 117 | skeletal muscle cell differentiation (GO:0035914) | 3.06534079 |
| 118 | neuromuscular junction development (GO:0007528) | 3.03678267 |
| 119 | cellular polysaccharide metabolic process (GO:0044264) | 3.02557655 |
| 120 | negative regulation of cAMP-mediated signaling (GO:0043951) | 3.02432356 |
| 121 | heart process (GO:0003015) | 3.00019936 |
| 122 | heart contraction (GO:0060047) | 3.00019936 |
| 123 | * muscle filament sliding (GO:0030049) | 13.1906913 |
| 124 | * actin-myosin filament sliding (GO:0033275) | 13.1906913 |
| 125 | regulation of skeletal muscle contraction (GO:0014819) | 12.6417214 |
| 126 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 10.8643422 |
| 127 | * actin-mediated cell contraction (GO:0070252) | 10.7431594 |
| 128 | * skeletal muscle contraction (GO:0003009) | 10.6569734 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 8.13453531 |
| 2 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.53730051 |
| 3 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.46984900 |
| 4 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.60928572 |
| 5 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 3.38349602 |
| 6 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 3.36573795 |
| 7 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 3.21445043 |
| 8 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 3.05599607 |
| 9 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.56795253 |
| 10 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.53597404 |
| 11 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 2.42097337 |
| 12 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 2.42097337 |
| 13 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.30776983 |
| 14 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.26364871 |
| 15 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.19633379 |
| 16 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 2.19386403 |
| 17 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 2.08844857 |
| 18 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.95784002 |
| 19 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.87279342 |
| 20 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.85589125 |
| 21 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.84280221 |
| 22 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.80680208 |
| 23 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.79956757 |
| 24 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.72767541 |
| 25 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.72286736 |
| 26 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.69946232 |
| 27 | * P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.69210060 |
| 28 | * CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.66726207 |
| 29 | * CTCF_27219007_Chip-Seq_Bcells_Human | 1.61070846 |
| 30 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.60869833 |
| 31 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.56564116 |
| 32 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.49330090 |
| 33 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.48488077 |
| 34 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.46986904 |
| 35 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.46920240 |
| 36 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.39536584 |
| 37 | SA1_27219007_Chip-Seq_Bcells_Human | 1.36400714 |
| 38 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 1.35985104 |
| 39 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.34425436 |
| 40 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.33605619 |
| 41 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.33585099 |
| 42 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.32164011 |
| 43 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.31662634 |
| 44 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.31330567 |
| 45 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.28909525 |
| 46 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.26101369 |
| 47 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.24513724 |
| 48 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.24108164 |
| 49 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.23551386 |
| 50 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.23089887 |
| 51 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.21990740 |
| 52 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.21588513 |
| 53 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.20706003 |
| 54 | OCT4_20526341_ChIP-Seq_ESCs_Human | 1.16971741 |
| 55 | * CTCF_21964334_Chip-Seq_Bcells_Human | 1.16686727 |
| 56 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.15411465 |
| 57 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.15223033 |
| 58 | * SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.12046723 |
| 59 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 1.11159833 |
| 60 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.11151624 |
| 61 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.10510409 |
| 62 | CJUN_26792858_Chip-Seq_BT549_Human | 1.09049486 |
| 63 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.08806758 |
| 64 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 1.08749641 |
| 65 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 1.08721677 |
| 66 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.07959473 |
| 67 | ATF3_27146783_Chip-Seq_COLON_Human | 1.07447850 |
| 68 | P68_20966046_ChIP-Seq_HELA_Human | 1.06728914 |
| 69 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.06038585 |
| 70 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.05491312 |
| 71 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.04535809 |
| 72 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.04535032 |
| 73 | CEBPB_22108803_ChIP-Seq_LS180_Human | 1.04485214 |
| 74 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.03942462 |
| 75 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.03876460 |
| 76 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.03535061 |
| 77 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.02999953 |
| 78 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.02999366 |
| 79 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.02880984 |
| 80 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.02741072 |
| 81 | RAC3_21632823_ChIP-Seq_H3396_Human | 1.02707899 |
| 82 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.02556763 |
| 83 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.02290436 |
| 84 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.02154193 |
| 85 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.02024397 |
| 86 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.01962407 |
| 87 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.99493031 |
| 88 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.98236787 |
| 89 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.97508580 |
| 90 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.97024602 |
| 91 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.96461088 |
| 92 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.96461088 |
| 93 | P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 0.96426890 |
| 94 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.96329696 |
| 95 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.96236310 |
| 96 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 0.96053831 |
| 97 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.94638737 |
| 98 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.94485000 |
| 99 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.94128507 |
| 100 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.92336143 |
| 101 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.92003438 |
| 102 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.91926970 |
| 103 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.91341094 |
| 104 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 0.90922665 |
| 105 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.90798727 |
| 106 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.90551106 |
| 107 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.90294563 |
| 108 | * E2F1_20622854_ChIP-Seq_HELA_Human | 0.89718320 |
| 109 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.88810870 |
| 110 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.88216466 |
| 111 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.87862999 |
| 112 | * BCL6_27268052_Chip-Seq_Bcells_Human | 0.87639821 |
| 113 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.87494558 |
| 114 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.87408139 |
| 115 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.87255981 |
| 116 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 0.86733879 |
| 117 | PRDM14_21183938_ChIP-Seq_MESCs_Mouse | 0.84254107 |
| 118 | * CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.84207205 |
| 119 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.83775342 |
| 120 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.83695135 |
| 121 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.83180538 |
| 122 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.82633295 |
| 123 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.82610804 |
| 124 | OCT1_27270436_Chip-Seq_PROSTATE_Human | 0.82513787 |
| 125 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.82501418 |
| 126 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.80890092 |
| 127 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.80740258 |
| 128 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.80710820 |
| 129 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.77685953 |
| 130 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.77526922 |
| 131 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.75643925 |
| 132 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.75448190 |
| 133 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.75448190 |
| 134 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.73792826 |
| 135 | DPY_21335234_ChIP-Seq_ESCs_Mouse | 0.72666146 |
| 136 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.67690170 |
| 137 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.67326486 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004145_abnormal_muscle_electrophysio | 7.78125519 |
| 2 | MP0000749_muscle_degeneration | 6.50093420 |
| 3 | MP0003646_muscle_fatigue | 5.90618188 |
| 4 | MP0000751_myopathy | 5.76724670 |
| 5 | MP0000747_muscle_weakness | 4.61859000 |
| 6 | MP0002106_abnormal_muscle_physiology | 4.24903398 |
| 7 | MP0000759_abnormal_skeletal_muscle | 3.85964489 |
| 8 | MP0004036_abnormal_muscle_relaxation | 3.83697015 |
| 9 | MP0005369_muscle_phenotype | 3.56441540 |
| 10 | MP0002269_muscular_atrophy | 3.46941429 |
| 11 | MP0004087_abnormal_muscle_fiber | 3.46243659 |
| 12 | MP0002837_dystrophic_cardiac_calcinosis | 3.43267174 |
| 13 | MP0000750_abnormal_muscle_regeneration | 3.29627336 |
| 14 | MP0004130_abnormal_muscle_cell | 3.20435877 |
| 15 | MP0005620_abnormal_muscle_contractility | 3.07175970 |
| 16 | MP0000733_abnormal_muscle_development | 2.61308083 |
| 17 | MP0004233_abnormal_muscle_weight | 2.44826456 |
| 18 | MP0002108_abnormal_muscle_morphology | 2.16969114 |
| 19 | MP0002332_abnormal_exercise_endurance | 2.13155728 |
| 20 | MP0005330_cardiomyopathy | 1.90124436 |
| 21 | MP0005275_abnormal_skin_tensile | 1.89375479 |
| 22 | MP0004185_abnormal_adipocyte_glucose | 1.80270157 |
| 23 | MP0006036_abnormal_mitochondrial_physio | 1.75228530 |
| 24 | MP0004084_abnormal_cardiac_muscle | 1.63077039 |
| 25 | MP0002971_abnormal_brown_adipose | 1.47752009 |
| 26 | MP0005666_abnormal_adipose_tissue | 1.42130583 |
| 27 | MP0004270_analgesia | 1.39929588 |
| 28 | MP0000013_abnormal_adipose_tissue | 1.34695998 |
| 29 | MP0002972_abnormal_cardiac_muscle | 1.28952801 |
| 30 | MP0003705_abnormal_hypodermis_morpholog | 1.28836647 |
| 31 | MP0004484_altered_response_of | 1.26518145 |
| 32 | MP0004215_abnormal_myocardial_fiber | 1.24856250 |
| 33 | MP0010630_abnormal_cardiac_muscle | 1.17612665 |
| 34 | MP0003950_abnormal_plasma_membrane | 1.14516452 |
| 35 | MP0005375_adipose_tissue_phenotype | 1.12871674 |
| 36 | MP0002796_impaired_skin_barrier | 1.05458947 |
| 37 | MP0002822_catalepsy | 1.04576045 |
| 38 | MP0003221_abnormal_cardiomyocyte_apopto | 1.02184614 |
| 39 | MP0001661_extended_life_span | 1.00424343 |
| 40 | MP0003806_abnormal_nucleotide_metabolis | 0.97901300 |
| 41 | MP0005266_abnormal_metabolism | 0.96643405 |
| 42 | MP0002234_abnormal_pharynx_morphology | 0.96105535 |
| 43 | MP0004134_abnormal_chest_morphology | 0.91785281 |
| 44 | MP0000762_abnormal_tongue_morphology | 0.85683228 |
| 45 | MP0005385_cardiovascular_system_phenoty | 0.81937598 |
| 46 | MP0001544_abnormal_cardiovascular_syste | 0.81937598 |
| 47 | MP0006035_abnormal_mitochondrial_morpho | 0.79561831 |
| 48 | MP0000579_abnormal_nail_morphology | 0.77097413 |
| 49 | MP0009250_abnormal_appendicular_skeleto | 0.72909802 |
| 50 | MP0000372_irregular_coat_pigmentation | 0.71141188 |
| 51 | MP0000003_abnormal_adipose_tissue | 0.70837347 |
| 52 | MP0001299_abnormal_eye_distance/ | 0.69939954 |
| 53 | MP0009780_abnormal_chondrocyte_physiolo | 0.69515720 |
| 54 | MP0003656_abnormal_erythrocyte_physiolo | 0.65020322 |
| 55 | MP0008961_abnormal_basal_metabolism | 0.64240867 |
| 56 | MP0008438_abnormal_cutaneous_collagen | 0.63598848 |
| 57 | MP0003137_abnormal_impulse_conducting | 0.59505167 |
| 58 | MP0004085_abnormal_heartbeat | 0.58969000 |
| 59 | MP0005503_abnormal_tendon_morphology | 0.58541523 |
| 60 | MP0001243_abnormal_dermal_layer | 0.58427608 |
| 61 | MP0005334_abnormal_fat_pad | 0.57707990 |
| 62 | MP0003879_abnormal_hair_cell | 0.57136687 |
| 63 | MP0000383_abnormal_hair_follicle | 0.56857085 |
| 64 | MP0005670_abnormal_white_adipose | 0.56568084 |
| 65 | MP0004147_increased_porphyrin_level | 0.56128165 |
| 66 | MP0005501_abnormal_skin_physiology | 0.55589143 |
| 67 | MP0000343_altered_response_to | 0.54393204 |
| 68 | MP0010030_abnormal_orbit_morphology | 0.53692131 |
| 69 | MP0002078_abnormal_glucose_homeostasis | 0.52368762 |
| 70 | MP0003045_fibrosis | 0.49394062 |
| 71 | MP0002896_abnormal_bone_mineralization | 0.48768896 |
| 72 | MP0000266_abnormal_heart_morphology | 0.47766975 |
| 73 | MP0002060_abnormal_skin_morphology | 0.47558105 |
| 74 | MP0004043_abnormal_pH_regulation | 0.46980463 |
| 75 | MP0002089_abnormal_postnatal_growth/wei | 0.44610156 |
| 76 | MP0008775_abnormal_heart_ventricle | 0.44586269 |
| 77 | MP0005452_abnormal_adipose_tissue | 0.44457346 |
| 78 | MP0002127_abnormal_cardiovascular_syste | 0.43905646 |
| 79 | MP0009672_abnormal_birth_weight | 0.42389005 |
| 80 | MP0008569_lethality_at_weaning | 0.41606727 |
| 81 | MP0000427_abnormal_hair_cycle | 0.40404686 |
| 82 | MP0001849_ear_inflammation | 0.40305890 |
| 83 | MP0004510_myositis | 0.39750771 |
| 84 | MP0005167_abnormal_blood-brain_barrier | 0.39633863 |
| 85 | MP0001346_abnormal_lacrimal_gland | 0.39497695 |
| 86 | MP0003959_abnormal_lean_body | 0.39384045 |
| 87 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.37948665 |
| 88 | MP0004142_abnormal_muscle_tone | 0.37465443 |
| 89 | MP0006138_congestive_heart_failure | 0.37028434 |
| 90 | MP0002114_abnormal_axial_skeleton | 0.36095159 |
| 91 | MP0005376_homeostasis/metabolism_phenot | 0.35549636 |
| 92 | MP0002128_abnormal_blood_circulation | 0.35538076 |
| 93 | MP0010678_abnormal_skin_adnexa | 0.35440825 |
| 94 | MP0000377_abnormal_hair_follicle | 0.34297294 |
| 95 | MP0002734_abnormal_mechanical_nocicepti | 0.34029000 |
| 96 | MP0009115_abnormal_fat_cell | 0.32793595 |
| 97 | MP0005535_abnormal_body_temperature | 0.32782481 |
| 98 | MP0002638_abnormal_pupillary_reflex | 0.32175871 |
| 99 | MP0005319_abnormal_enzyme/_coenzyme | 0.30214575 |
| 100 | MP0003948_abnormal_gas_homeostasis | 0.30120145 |
| 101 | MP0005083_abnormal_biliary_tract | 0.29984150 |
| 102 | MP0005451_abnormal_body_composition | 0.28622557 |
| 103 | MP0002249_abnormal_larynx_morphology | 0.27679610 |
| 104 | MP0009931_abnormal_skin_appearance | 0.27476229 |
| 105 | MP0010771_integument_phenotype | 0.25530583 |
| 106 | MP0005165_increased_susceptibility_to | 0.25389748 |
| 107 | MP0005166_decreased_susceptibility_to | 0.25388239 |
| 108 | MP0000230_abnormal_systemic_arterial | 0.24373680 |
| 109 | MP0000647_abnormal_sebaceous_gland | 0.23398955 |
| 110 | MP0005423_abnormal_somatic_nervous | 0.22360786 |
| 111 | MP0001853_heart_inflammation | 0.21544263 |
| 112 | MP0000467_abnormal_esophagus_morphology | 0.21484957 |
| 113 | MP0001943_abnormal_respiration | 0.21333098 |
| 114 | MP0003828_pulmonary_edema | 0.21052385 |
| 115 | MP0010234_abnormal_vibrissa_follicle | 0.20313069 |
| 116 | MP0003385_abnormal_body_wall | 0.20044505 |
| 117 | MP0008770_decreased_survivor_rate | 0.20015637 |
| 118 | MP0004197_abnormal_fetal_growth/weight/ | 0.19470875 |
| 119 | MP0005332_abnormal_amino_acid | 0.18553636 |
| 120 | MP0004858_abnormal_nervous_system | 0.18043378 |
| 121 | MP0002066_abnormal_motor_capabilities/c | 0.17974194 |
| 122 | MP0006276_abnormal_autonomic_nervous | 0.17919771 |
| 123 | MP0003011_delayed_dark_adaptation | 0.14797708 |
| 124 | MP0005187_abnormal_penis_morphology | 0.12930546 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nemaline bodies (HP:0003798) | 9.98333652 |
| 2 | Exercise-induced myalgia (HP:0003738) | 8.58317104 |
| 3 | Type 1 muscle fiber predominance (HP:0003803) | 8.37334806 |
| 4 | Exercise-induced muscle cramps (HP:0003710) | 7.66674504 |
| 5 | Myopathic facies (HP:0002058) | 7.22182934 |
| 6 | * Distal arthrogryposis (HP:0005684) | 7.00247176 |
| 7 | Muscle hypertrophy of the lower extremities (HP:0008968) | 6.51595087 |
| 8 | Calf muscle hypertrophy (HP:0008981) | 5.86826989 |
| 9 | Muscle fiber splitting (HP:0003555) | 5.38987255 |
| 10 | Difficulty running (HP:0009046) | 5.33279701 |
| 11 | Hyporeflexia of lower limbs (HP:0002600) | 5.05926060 |
| 12 | Myoglobinuria (HP:0002913) | 5.02516811 |
| 13 | * Round ear (HP:0100830) | 4.95722729 |
| 14 | * Ulnar deviation of the wrist (HP:0003049) | 4.81694453 |
| 15 | EMG: myopathic abnormalities (HP:0003458) | 4.68637701 |
| 16 | Increased connective tissue (HP:0009025) | 4.62162993 |
| 17 | Muscle stiffness (HP:0003552) | 4.53918892 |
| 18 | Abnormality of skeletal muscle fiber size (HP:0012084) | 4.23393148 |
| 19 | Rhabdomyolysis (HP:0003201) | 4.20069533 |
| 20 | Abnormality of the calf musculature (HP:0001430) | 4.11969266 |
| 21 | * Calcaneovalgus deformity (HP:0001848) | 4.07335658 |
| 22 | * Absent phalangeal crease (HP:0006109) | 3.97261448 |
| 23 | Myotonia (HP:0002486) | 3.96437256 |
| 24 | Neck muscle weakness (HP:0000467) | 3.90000911 |
| 25 | * Deformed tarsal bones (HP:0008119) | 3.87010068 |
| 26 | Malignant hyperthermia (HP:0002047) | 3.81897308 |
| 27 | Increased variability in muscle fiber diameter (HP:0003557) | 3.71840664 |
| 28 | Frequent falls (HP:0002359) | 3.67184711 |
| 29 | Rimmed vacuoles (HP:0003805) | 3.62046095 |
| 30 | Subaortic stenosis (HP:0001682) | 3.42020625 |
| 31 | Abnormality of the left ventricular outflow tract (HP:0011103) | 3.42020625 |
| 32 | Difficulty climbing stairs (HP:0003551) | 3.33361863 |
| 33 | * Abnormal finger flexion creases (HP:0006143) | 3.24241809 |
| 34 | Areflexia of lower limbs (HP:0002522) | 3.21970937 |
| 35 | Slender build (HP:0001533) | 3.21549445 |
| 36 | Pelvic girdle muscle weakness (HP:0003749) | 3.12668021 |
| 37 | Shoulder girdle muscle weakness (HP:0003547) | 3.11687725 |
| 38 | Abnormality of the musculature of the pelvis (HP:0001469) | 3.01722404 |
| 39 | Abnormality of the hip-girdle musculature (HP:0001445) | 3.01722404 |
| 40 | Fatigable weakness (HP:0003473) | 2.91662640 |
| 41 | Abnormality of the neuromuscular junction (HP:0003398) | 2.91662640 |
| 42 | Hyperkalemia (HP:0002153) | 2.85744857 |
| 43 | Asymmetric septal hypertrophy (HP:0001670) | 2.75605010 |
| 44 | Popliteal pterygium (HP:0009756) | 2.73440282 |
| 45 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.70573102 |
| 46 | EMG: neuropathic changes (HP:0003445) | 2.68085035 |
| 47 | Distal lower limb muscle weakness (HP:0009053) | 2.66935827 |
| 48 | Bundle branch block (HP:0011710) | 2.66517890 |
| 49 | Bulbar palsy (HP:0001283) | 2.60106836 |
| 50 | Sudden death (HP:0001699) | 2.59675022 |
| 51 | Spinal rigidity (HP:0003306) | 2.54467526 |
| 52 | Paralysis (HP:0003470) | 2.51488885 |
| 53 | Fetal akinesia sequence (HP:0001989) | 2.51343407 |
| 54 | Generalized muscle weakness (HP:0003324) | 2.48010092 |
| 55 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.42677726 |
| 56 | Muscular dystrophy (HP:0003560) | 2.35544217 |
| 57 | Facial diplegia (HP:0001349) | 2.31144193 |
| 58 | Scapular winging (HP:0003691) | 2.30534396 |
| 59 | Gowers sign (HP:0003391) | 2.29951422 |
| 60 | * Abnormality of the calcaneus (HP:0008364) | 2.29539635 |
| 61 | Weak cry (HP:0001612) | 2.26420521 |
| 62 | Nonprogressive disorder (HP:0003680) | 2.23304570 |
| 63 | Proximal amyotrophy (HP:0007126) | 2.22173811 |
| 64 | Limb-girdle muscle weakness (HP:0003325) | 2.19647119 |
| 65 | Hypoplastic ischia (HP:0003175) | 2.16784630 |
| 66 | Abnormality of the shoulder girdle musculature (HP:0001435) | 2.15872691 |
| 67 | Limb-girdle muscle atrophy (HP:0003797) | 2.09467165 |
| 68 | Distal lower limb amyotrophy (HP:0008944) | 2.05879677 |
| 69 | Abnormality of placental membranes (HP:0011409) | 2.01840878 |
| 70 | Amniotic constriction ring (HP:0009775) | 2.01840878 |
| 71 | Waddling gait (HP:0002515) | 2.01342215 |
| 72 | Muscle fiber inclusion bodies (HP:0100299) | 10.7774618 |
| 73 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 10.4124603 |
| 74 | Progressive muscle weakness (HP:0003323) | 1.97109581 |
| 75 | Hip contracture (HP:0003273) | 1.91419218 |
| 76 | Abnormality of the ischium (HP:0003174) | 1.88890003 |
| 77 | Achilles tendon contracture (HP:0001771) | 1.88580948 |
| 78 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 1.84695820 |
| 79 | Respiratory insufficiency due to muscle weakness (HP:0002747) | 1.73147358 |
| 80 | Heart block (HP:0012722) | 1.72685726 |
| 81 | Exercise intolerance (HP:0003546) | 1.70894368 |
| 82 | Abnormality of the Achilles tendon (HP:0005109) | 1.70871284 |
| 83 | * Ulnar deviation of finger (HP:0009465) | 1.70742906 |
| 84 | Ventricular tachycardia (HP:0004756) | 1.69322758 |
| 85 | Limited hip movement (HP:0008800) | 1.65143407 |
| 86 | Long clavicles (HP:0000890) | 1.64275182 |
| 87 | Abnormal atrioventricular conduction (HP:0005150) | 1.63569671 |
| 88 | * Metatarsus adductus (HP:0001840) | 1.59566425 |
| 89 | Ragged-red muscle fibers (HP:0003200) | 1.58636496 |
| 90 | Congenital hip dislocation (HP:0001374) | 1.58017098 |
| 91 | Breech presentation (HP:0001623) | 1.58000700 |
| 92 | Short palpebral fissure (HP:0012745) | 1.56991280 |
| 93 | Type 2 muscle fiber atrophy (HP:0003554) | 1.56914689 |
| 94 | Easy fatigability (HP:0003388) | 1.52498113 |
| 95 | Lower limb amyotrophy (HP:0007210) | 1.50767482 |
| 96 | Cholelithiasis (HP:0001081) | 1.50728432 |
| 97 | Aplasia of the musculature (HP:0100854) | 1.48598310 |
| 98 | Increased density of long bones (HP:0006392) | 1.47103606 |
| 99 | Stridor (HP:0010307) | 1.47014406 |
| 100 | Hyperuricemia (HP:0002149) | 1.46328451 |
| 101 | Increased purine levels (HP:0004368) | 1.46328451 |
| 102 | Foot dorsiflexor weakness (HP:0009027) | 1.45743681 |
| 103 | Abnormality of potassium homeostasis (HP:0011042) | 1.45704605 |
| 104 | Ventricular arrhythmia (HP:0004308) | 1.44941427 |
| 105 | Dilated cardiomyopathy (HP:0001644) | 1.43308766 |
| 106 | Lipoatrophy (HP:0100578) | 1.42931191 |
| 107 | Muscle fiber atrophy (HP:0100295) | 1.42080254 |
| 108 | Mesomelia (HP:0003027) | 1.39977334 |
| 109 | Increased intramyocellular lipid droplets (HP:0012240) | 1.38393545 |
| 110 | Steppage gait (HP:0003376) | 1.37088631 |
| 111 | Abnormality of the foot musculature (HP:0001436) | 1.36969909 |
| 112 | Right ventricular cardiomyopathy (HP:0011663) | 1.35760964 |
| 113 | Gout (HP:0001997) | 1.35431751 |
| 114 | * Ulnar deviation of the hand or of fingers of the hand (HP:0001193) | 1.34957562 |
| 115 | Oligomenorrhea (HP:0000876) | 1.33282585 |
| 116 | Increased muscle lipid content (HP:0009058) | 1.27574948 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | OBSCN | 9.04094535 |
| 2 | TTN | 6.11308563 |
| 3 | PHKG2 | 5.19052071 |
| 4 | PHKG1 | 5.19052071 |
| 5 | PIK3CG | 4.35703667 |
| 6 | NME1 | 4.25776705 |
| 7 | MAP2K3 | 2.94575316 |
| 8 | NEK1 | 2.26317955 |
| 9 | TRIB3 | 2.24528518 |
| 10 | MAP3K7 | 2.06054370 |
| 11 | PINK1 | 1.90447462 |
| 12 | PDK3 | 1.77694536 |
| 13 | PDK4 | 1.77694536 |
| 14 | DMPK | 1.70237082 |
| 15 | MAPK12 | 1.58218206 |
| 16 | MUSK | 1.58030317 |
| 17 | PIK3CA | 1.56408469 |
| 18 | MAP2K4 | 1.48039605 |
| 19 | MAP2K6 | 1.42086575 |
| 20 | BCKDK | 1.34228795 |
| 21 | MAP3K3 | 1.16292614 |
| 22 | PDK2 | 1.15538188 |
| 23 | MAPKAPK3 | 1.12571855 |
| 24 | NEK9 | 0.88268471 |
| 25 | MARK1 | 0.86402767 |
| 26 | TAOK2 | 0.82670308 |
| 27 | MAP3K13 | 0.81912831 |
| 28 | PRKAA2 | 0.78146642 |
| 29 | PKN2 | 0.74203724 |
| 30 | PRKAA1 | 0.73940200 |
| 31 | TRPM7 | 0.73218495 |
| 32 | TAOK1 | 0.71185191 |
| 33 | MAP3K11 | 0.66695146 |
| 34 | EPHB1 | 0.66179296 |
| 35 | ERBB3 | 0.65658012 |
| 36 | SIK1 | 0.65419695 |
| 37 | AKT2 | 0.65250304 |
| 38 | MAPK11 | 0.64847856 |
| 39 | STK24 | 0.60902495 |
| 40 | ZAK | 0.60619806 |
| 41 | RIPK1 | 0.55397345 |
| 42 | CAMK2G | 0.54883355 |
| 43 | ILK | 0.54165132 |
| 44 | CAMK4 | 0.53511797 |
| 45 | LIMK1 | 0.49632875 |
| 46 | EEF2K | 0.46086248 |
| 47 | PTK6 | 0.42993236 |
| 48 | ERN1 | 0.40211957 |
| 49 | CAMK2A | 0.36701699 |
| 50 | ARAF | 0.35353110 |
| 51 | CAMK1 | 0.35019891 |
| 52 | CAMK2B | 0.34138248 |
| 53 | MAP3K6 | 0.34094633 |
| 54 | MAP3K5 | 0.32839964 |
| 55 | TBK1 | 0.32816550 |
| 56 | MAP3K1 | 0.29405469 |
| 57 | PRKG1 | 0.28764028 |
| 58 | CDK19 | 0.28515738 |
| 59 | MAP3K10 | 0.27271082 |
| 60 | MAPK13 | 0.26433601 |
| 61 | RPS6KB1 | 0.26327532 |
| 62 | MOS | 0.26152111 |
| 63 | SGK2 | 0.25866098 |
| 64 | MAP2K1 | 0.25787342 |
| 65 | KSR2 | 0.25632010 |
| 66 | LATS1 | 0.24639552 |
| 67 | PRKACB | 0.24107491 |
| 68 | ROCK1 | 0.23550322 |
| 69 | TGFBR2 | 0.22674434 |
| 70 | PKN1 | 0.22428279 |
| 71 | RPS6KA3 | 0.21869383 |
| 72 | MAPK4 | 0.21831876 |
| 73 | MARK2 | 0.21627785 |
| 74 | MST1R | 0.21377575 |
| 75 | PRPF4B | 0.20724772 |
| 76 | LRRK2 | 0.20505045 |
| 77 | TYK2 | 0.18609071 |
| 78 | MAPK7 | 0.17729271 |
| 79 | PDPK1 | 0.17722559 |
| 80 | PRKACA | 0.17026644 |
| 81 | TIE1 | 0.15276523 |
| 82 | PRKD1 | 0.15141149 |
| 83 | FER | 0.14967212 |
| 84 | DYRK1B | 0.14456874 |
| 85 | DAPK2 | 0.14315768 |
| 86 | RAF1 | 0.14104409 |
| 87 | PDK1 | 0.13301573 |
| 88 | MAP3K9 | 0.12330672 |
| 89 | CAMK1G | 0.12240105 |
| 90 | ZAP70 | 0.11670209 |
| 91 | LATS2 | 0.11567168 |
| 92 | RPS6KB2 | 0.11425163 |
| 93 | RPS6KL1 | 0.10891163 |
| 94 | RPS6KC1 | 0.10891163 |
| 95 | BMX | 0.10643170 |
| 96 | RPS6KA1 | 0.08603131 |
| 97 | DDR2 | 0.08494526 |
| 98 | BRAF | 0.08072651 |
| 99 | ICK | 0.07931209 |
| 100 | INSRR | 0.07671912 |
| 101 | SGK223 | 0.07649710 |
| 102 | SGK494 | 0.07649710 |
| 103 | MARK3 | 0.07521968 |
| 104 | FGFR1 | 0.07243187 |
| 105 | RPS6KA6 | 0.06676018 |
| 106 | ROCK2 | 0.06296143 |
| 107 | TNK2 | 0.06016106 |
| 108 | KSR1 | 0.05957771 |
| 109 | JAK2 | 0.05061500 |
| 110 | FGFR3 | 0.04419255 |
| 111 | PAK6 | 0.04369134 |
| 112 | MTOR | 0.04243776 |
| 113 | PRKG2 | 0.03859076 |
| 114 | STK11 | 0.03573639 |
| 115 | NLK | 0.03079399 |
| 116 | GSK3A | 0.02923742 |
| 117 | PRKACG | 0.02650406 |
| 118 | MAPK8 | 0.02146425 |
| 119 | FLT3 | 0.01991968 |
| 120 | EPHA3 | 0.01605599 |
| 121 | MAPK10 | 0.01415567 |
| 122 | MAPKAPK2 | 0.01384222 |
| 123 | CSNK1D | 0.01069752 |
| 124 | PDGFRA | 0.01059762 |
| 125 | SGK3 | 0.00946970 |
| 126 | CDK6 | 0.00882527 |
| 127 | * SGK1 | -0.0167065 |
| 128 | CCNB1 | -0.0165566 |
| 129 | PTK2B | -0.0047088 |
| 130 | CAMK2D | -0.0012122 |
| 131 | RET | -0.0009172 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 4.37472668 |
| 2 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 4.06989143 |
| 3 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 3.93687615 |
| 4 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 3.55465802 |
| 5 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 3.55006366 |
| 6 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 3.18199867 |
| 7 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 3.02528493 |
| 8 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 2.34167541 |
| 9 | Insulin signaling pathway_Homo sapiens_hsa04910 | 2.31922002 |
| 10 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 2.24980757 |
| 11 | Insulin resistance_Homo sapiens_hsa04931 | 2.17070385 |
| 12 | Circadian rhythm_Homo sapiens_hsa04710 | 2.14613657 |
| 13 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.12845938 |
| 14 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 2.10172208 |
| 15 | Carbon metabolism_Homo sapiens_hsa01200 | 2.06944691 |
| 16 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.95027770 |
| 17 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.81087704 |
| 18 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.78804467 |
| 19 | AMPK signaling pathway_Homo sapiens_hsa04152 | 1.70348114 |
| 20 | Galactose metabolism_Homo sapiens_hsa00052 | 1.67617095 |
| 21 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.64201755 |
| 22 | Tight junction_Homo sapiens_hsa04530 | 1.55605246 |
| 23 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.52856947 |
| 24 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.45761890 |
| 25 | Alzheimers disease_Homo sapiens_hsa05010 | 1.45729777 |
| 26 | Viral myocarditis_Homo sapiens_hsa05416 | 1.44949327 |
| 27 | Parkinsons disease_Homo sapiens_hsa05012 | 1.43393481 |
| 28 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.43155995 |
| 29 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.37171678 |
| 30 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.31377531 |
| 31 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 1.27751130 |
| 32 | Focal adhesion_Homo sapiens_hsa04510 | 1.23852219 |
| 33 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.23269488 |
| 34 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.23194848 |
| 35 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.13230521 |
| 36 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.12089821 |
| 37 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.11118547 |
| 38 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.10913765 |
| 39 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.07605433 |
| 40 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.03464071 |
| 41 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.03386319 |
| 42 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.00643470 |
| 43 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.94089183 |
| 44 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.92567603 |
| 45 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.87556186 |
| 46 | Long-term potentiation_Homo sapiens_hsa04720 | 0.87513290 |
| 47 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.83685207 |
| 48 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.82257626 |
| 49 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.81973269 |
| 50 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.80165001 |
| 51 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.74808932 |
| 52 | Renin secretion_Homo sapiens_hsa04924 | 0.70427127 |
| 53 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.70071849 |
| 54 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.69909800 |
| 55 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.67890985 |
| 56 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.67855407 |
| 57 | Platelet activation_Homo sapiens_hsa04611 | 0.66437793 |
| 58 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.64760299 |
| 59 | Amoebiasis_Homo sapiens_hsa05146 | 0.60763235 |
| 60 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.60225434 |
| 61 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.59937094 |
| 62 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.57017570 |
| 63 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.54716184 |
| 64 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.53428667 |
| 65 | Adherens junction_Homo sapiens_hsa04520 | 0.52754945 |
| 66 | Circadian entrainment_Homo sapiens_hsa04713 | 0.46328529 |
| 67 | Huntingtons disease_Homo sapiens_hsa05016 | 0.43691978 |
| 68 | Insulin secretion_Homo sapiens_hsa04911 | 0.43340233 |
| 69 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.42205655 |
| 70 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.41990958 |
| 71 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.41382142 |
| 72 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.40867028 |
| 73 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.37988460 |
| 74 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.34659745 |
| 75 | Long-term depression_Homo sapiens_hsa04730 | 0.34495683 |
| 76 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.34216610 |
| 77 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.32883196 |
| 78 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.32045340 |
| 79 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.31707688 |
| 80 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.29987198 |
| 81 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.26706121 |
| 82 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.26371969 |
| 83 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.24543903 |
| 84 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.23967812 |
| 85 | Peroxisome_Homo sapiens_hsa04146 | 0.23921504 |
| 86 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.22917618 |
| 87 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.22628709 |
| 88 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.22626136 |
| 89 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.22472157 |
| 90 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.21842419 |
| 91 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.21628324 |
| 92 | Lysine degradation_Homo sapiens_hsa00310 | 0.20956491 |
| 93 | Histidine metabolism_Homo sapiens_hsa00340 | 0.20551329 |
| 94 | Thyroid cancer_Homo sapiens_hsa05216 | 0.20216133 |
| 95 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.19982628 |
| 96 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.19961459 |
| 97 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.18991433 |
| 98 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.18986804 |
| 99 | Phototransduction_Homo sapiens_hsa04744 | 0.17347936 |
| 100 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.17037222 |
| 101 | Salivary secretion_Homo sapiens_hsa04970 | 0.16995191 |
| 102 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.16106863 |
| 103 | Melanogenesis_Homo sapiens_hsa04916 | 0.15288824 |
| 104 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.14247301 |
| 105 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.14055929 |
| 106 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.12661634 |
| 107 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.10993015 |
| 108 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.09574818 |
| 109 | Olfactory transduction_Homo sapiens_hsa04740 | 0.09085420 |
| 110 | Glioma_Homo sapiens_hsa05214 | 0.08489462 |
| 111 | Legionellosis_Homo sapiens_hsa05134 | 0.08448105 |
| 112 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.07337767 |
| 113 | Purine metabolism_Homo sapiens_hsa00230 | 0.07313390 |
| 114 | Pertussis_Homo sapiens_hsa05133 | 0.07189686 |
| 115 | Salmonella infection_Homo sapiens_hsa05132 | 0.07127221 |
| 116 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.07046125 |
| 117 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.06365438 |
| 118 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.06179125 |
| 119 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.05950635 |

